placebo
controlled
trial
cephalexin
therapy
ambulatory
management
patients
cystic
fibrosis
effects
oral
administration
cephalexin
evaluated
double
blind
placebo
controlled
crossover
study
patients
mild
moderate
pulmonary
disease
due
cystic
fibrosis
two
years
four
month
periods
cephalexin
alternated
four
month
placebo
periods
thus
patients
served
control
subjects
fungal
vulvovaginitis
occurred
two
patients
cephalexin
therapy
years
study
rate
colonization
mucoid
strains
pseudomonas
aeruginosa
increased
disease
severity
deteriorated
patients
initially
colonized
p
aeruginosa
short
term
courses
sputum
culture
specific
antibiotics
improved
course
patients
mild
moderate
pulmonary
disease
due
cystic
fibrosis
treatment
cephalexin
decreased
frequency
respiratory
illnesses
respiratory
illnesses
requiring
antibiotics
hospitalizations
respiratory
illnesses
patients
initially
colonized
staphylococcus
aureus
haemophilus
influenzae
also
reduced
colonization
organisms
improved
weight
gain
patients
associated
periods
cephalexin
therapy
pulmonary
function
tests
remained
stable
improved
patients
disease
severity
improved
patients
colonized
p
aeruginosa
